Qulab Inc. develops advanced computational methods to automate molecular drug design by leveraging on the power of classical and quantum computers.
QuleapTM is the first fully-integrated AI-platform for de novo small molecule drug design.
No services posted yet
This data is part of our proprietary analytics report:
This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality